November 2026
Featured
Events
Bridging Obesity and MASLD Through Metabolic Dysfunction (Non-CME)
Riverview Ballroom A
Supported by: Boehringer Ingelheim Pharmaceuticals, Inc.
Obesity in Focus: Today’s evidence. Tomorrow’s possibilities. (Non-CME)
Gaylord National Resort & Convention Center, Exhibit Hall A
Supported by: Novo
November 2026
Events
Rethinking Success in the Treatment of Overweight and Obesity Through Body Composition: What Are We Made of?
Riverview Ballroom A
The Obesity Treatment Journey: Overcoming Burden, Discontinuation, Supporting Outcomes
Riverview Ballroom B
Weight Management: Foundayo
Exhibit Hall A
Bridging Obesity and MASLD Through Metabolic Dysfunction (Non-CME)
Riverview Ballroom A
Supported by: Boehringer Ingelheim Pharmaceuticals, Inc.
Not All Obesity Is the Same: Identifying Rare Neuroendocrine Causes
Riverview Ballroom B
Obesity in Focus: Today’s evidence. Tomorrow’s possibilities. (Non-CME)
Gaylord National Resort & Convention Center, Exhibit Hall A
Supported by: Novo
One Patient, Many Perspectives: A Multidisciplinary Expert Roundtable on Obesity Care
Riverview Ballroom B
Seen Beyond the Scale: Addressing Weight Bias and Stigma in Pediatric Obesity Care
Riverview Ballroom B
The Missing Link: Diagnosing & Managing Acquired Hypothalamic Obesity
Exhibit Hall A
Disease State Education on Obesity/MASH
Riverview Ballroom B
The Evolution of Obesity Management: Incorporating a Maturing Science into Clinical Practice
Riverview Ballroom A
Exploring Zepbound (Tirzepatide) Injection With a Clinical Expert
Exhibit Hall A
This program is sponsored by, and presented on behalf of, Lilly USA, LLC.



